Clinical Trial: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Pilot Study for Comparative Clinical Trial on the Therapeutic Effect of Tacrolimus (Prograf Cap®) in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Synd

Brief Summary: The hypothesis of this study is that tacrolimus reduces the proteinuria in adult patient with minimal change nephritic syndrome.

Detailed Summary: A pilot study for comparative clinical trial on the therapeutic effect of tacrolimus (Prograf cap®) in adult patient with minimal change nephritic syndrome.
Sponsor: Seoul National University Hospital

Current Primary Outcome: remission of proteinuria [ Time Frame: 12 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: time to remission, relapse rate, response failure rate [ Time Frame: 12 weeks ]

Original Secondary Outcome: Same as current

Information By: Seoul National University Hospital

Dates:
Date Received: March 10, 2010
Date Started: June 2010
Date Completion:
Last Updated: August 12, 2011
Last Verified: August 2011